Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal Disorders, Cardiovascular Diseases, Gastrointestinal Diseases, Wounds and Injuries, Surgeries) - Analysis & Forecast 2019-2030

Report ID : 32  |  Published Date : Feb 2019  |  Pages : 150  |  Region : Global  |  Report Code : BT-9




Stem Cell Therapy Market Overview and Introduction

The global Stem Cell Therapy market was valued at over US$ 200.0 Mn by 2030 and is expected to grow at a double digit CAGR over the forecast period. The global stem cell therapy market is segmented by type, therapeutic application, and region.

Stem cells are cells which have ability to differentiate into various types of other cells and ultimately form organs or tissues. Stem cells are mainly of two type embryonic stem cells and adult stem cells. Over the years many researchers have carried out studies to evaluate the true potential of stem cells leading to various applications in the field of organ regeneration, genetic diseases treatment, oncology and cell therapy in damaged cells.  

The global stem cell therapy market is driven by technological advancements in the stem cell therapy arena, increasing patient awareness and health care expenditure, rising number of patients genetic disorders, and need for regenerative medicine are major factors driving the market. However, high cost related to stem cell therapy research and ethical issue related to stem cells is likely to restrain the market to certain extent.

Stem Cell Therapy Market by Type

On the basis of type, the stem cell therapy market is segmented into allogeneic stem cell therapy and autologous stem cell therapy.

Stem Cell Therapy Market by Therapeutic 

Allogeneic stem cell therapy segments accounted for the largest share of the market. Growth of this segment can be attributed to increasing focus on commercializing allogeneic stem cell products by companies to cater to a broad range of therapeutic applications.

Stem Cell Therapy Market by Application 

Based on application, the market is segmented into musculoskeletal disorders, cardiovascular diseases, gastrointestinal diseases, wounds and injuries, surgeries and other applications.

Stem Cell Therapy Market by Regions 

The global stem cell therapy market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).  North America dominated the market of stem cell therapy market, followed by Europe and Asia Pacific. North America and other regions like Asia Pacific is anticipated to dominate the global stem cell therapy market in the forecast period owing to factors such as growing need of stem cell therapy products, advancement in technology, highly developed healthcare system and availability of government and private funding for research on stem cell.

Stem Cell Therapy Market Prominent Players 

The prominent players in the global Stem Cell Therapy market are Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Ltd, Holostem Terapie Avanzate S.r.l, .JCR Pharmaceuticals Co., NuVasive, Inc., RTI Surgical, Inc , and  AlloSource

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.   Market Classification
      2.   Geographic Scope
      3.   Years Considered for the Study
        1. Historical Years – 2016 & 2017
        2. Base Year – 2018
        3. Forecasted Years – 2019 to 2030
    3. Currency Used for the Study
    4. Report Beneficiary List
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.   Bottoms Up Approach
      2.   Top Down Approach
    5. Data Validation and Triangulation
      1.   Market Forecasting Model
      2.   Limitations of the Study
      3.   Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Application Horizon Assessment
    2.   Initiatives Assessment: Government & Private Bodies
    3. Regulatory Scenario Snapshot
  6. GLOBAL STEM CELL THERAPY MARKET - ANALYSIS & FORECAST, BY TYPE
    1. Introduction
    2. Allogeneic Stem Cell therapy
    3. Autologous Stem Cell therapy
  7. GLOBAL STEM CELL THERAPY MARKET - ANALYSIS & FORECAST, BY THERAPEUTIC APPLICATION
    1. Introduction 
    2. Musculoskeletal Disorders
    3. Cardiovascular Diseases
    4. Gastrointestinal Diseases
    5. Wounds and Injuries
    6. Surgeries
    7. Other Applications
  8. GLOBAL STEM CELL THERAPY MARKET - ANALYSIS & FORECAST, BY REGION
    1.     North America Stem Cell Therapy Market
      1.   North America Stem Cell Therapy Market, By Country
        1.  US
        2.  Canada
      2. North America Stem Cell Therapy Market Analysis & Forecast, By Type
      3. North America Stem Cell Therapy Market Analysis & Forecast, By Application
    2. Europe Stem Cell Therapy Market
      1. Europe Stem Cell Therapy Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Stem Cell Therapy Market Analysis & Forecast, By Type
      3. Europe Stem Cell Therapy Market Analysis & Forecast, By Application
    3. Asia Pacific Stem Cell Therapy Market
      1. Asia Pacific Stem Cell Therapy Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Stem Cell Therapy Market Analysis & Forecast, By Product  &  Services
      3. Asia Pacific Stem Cell Therapy Market Analysis & Forecast, By Application
    4.    Rest of the World (ROW) Stem Cell Therapy Market
      1. Rest of the World Stem Cell Therapy Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Stem Cell Therapy Market Analysis & Forecast, By  Type
      3. Rest of the World Stem Cell Therapy Market Analysis & Forecast, By Application
  9. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Other Strategies
  10. COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1.    Osiris  
    2.    MEDIPOST
    3.    Anterogen
    4.    PHARMICELL Co., Ltd
    5.    Holostem Terapie Avanzate S.r.l
    6.    JCR Pharmaceuticals Co.
    7.   NuVasive, Inc.
    8.   RTI Surgical, Inc 
    9.   AlloSource  (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
  11. APPENDIX
    1. Questionnaire
    2. Primary Interviews Transcripts
    3.    Customization Options
    4. Profile of the Author